You absolutely can. Where is the restriction? It's common for pharmaceutical companies to synthesise competitor compounds to get a read on invivo PK/PD etc. And this isn't a clinical study so this isn't a case of anything unprofessional or rushed, it's a simple lab experiment. I'm not questioning if either have GMP product, obviously they do as the are running studies... but it's not required to put in a dish with some cells and it's misguided to beleive this indicates an ongoing collaboration
You absolutely can. Where is the restriction? It's common for...
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
46.0¢ |
Change
-0.005(1.08%) |
Mkt cap ! $253.1M | |||
| Open | High | Low | Value | Volume |
| 47.0¢ | 49.0¢ | 45.5¢ | $1.771M | 3.761M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 34765 | 46.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 46.5¢ | 26998 | 1 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| DXB (ASX) Chart |